Submit to Special Issue Submit Abstract to Special Issue Review for Vaccines Propose a Special Issue

Journal Menu

Journal Browser

Special Issue "Vaccination Progress in COVID-19 and HPV"

Print Special Issue Flyer
Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Papillomavirus Vaccines".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 2132

Share This Special Issue

Special Issue Editor

Dr. Wangnan Cao

E-Mail Website
Guest Editor

Department of Social Medicine and Health Education, School of Public Health, Peking University Health Science Center, Beijing 100191, China
Interests: HIV/AIDS; behavioral intervention; health promotion; health behavior theories; COVID-19; PrEP; mental health; infectious diseases; behavioral health and health promotion
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vaccines to prevent SARS-CoV-2 infection are considered the most promising approach for curbing the COVID-19 pandemic. Over a year into the biggest vaccination campaign in history, more than 12.7 billion doses have been administered across 184 countries. The human papillomavirus (HPV) vaccine helps to protect against cancers caused by HPV, including cervical cancer, some mouth and throat cancers, and some cancers of the anal and genital areas. The current global COVID-19 pandemic threatens to derail the uptake of HPV vaccination in low- and lower-middle income countries, which has a major impact on the World Health Organization cervical cancer elimination strategy, which is dependent on HPV vaccination as well as cervical cancer screening and treatment. This Special Issue welcomes submissions across the broadest interpretation of these issues, including but definitely not restricted to the following:

COVID-19 vaccination progress, particularly among vulnerable subpopulations (e.g., elders, people living with HIV);
HPV vaccination in different geographic regions, particularly low- and lower-middle income countries;
HPV vaccination progress during the COVID-19 pandemic;
Behavioral interventions to support COVID-19 and HPV vaccination;
Long-term evaluations of COVID-19 and HPV vaccination.

Dr. Wangnan Cao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

COVID-19 vaccination
HPV vaccination
human papillomavirus
vaccine hesitancy
vaccination willingness
elderly
vulnerable population

Published Papers (3 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Jump to: Other

Open AccessArticle

National HPV Vaccination Program in Poland—Public Awareness, Sources of Knowledge, and Willingness to Vaccinate Children against HPV

Mateusz Jankowski

Justyna Grudziąż-Sękowska

Iwona Wrześniewska-Wal

and

Vaccines 2023, 11(8), 1371; https://doi.org/10.3390/vaccines11081371 - 16 Aug 2023

Viewed by 592

Abstract

Since 1 June 2023, a nationwide HPV vaccination program was implemented in Poland. This study aimed to identify factors associated with public awareness of the national HPV vaccination program among adults in Poland and willingness to vaccinate children against HPV. This cross-sectional study was carried out between 14 and 17 July 2023 among 1056 adults in Poland. A self-prepared questionnaire was used. Among the respondents, 51.3% had heard about the free HPV vaccination program. The major source of knowledge on the national HPV vaccination program was TV (62%). Only 31.9% of respondents correctly indicated girls and boys aged 12 and 13 as the HPV-vaccination-eligible population. Willingness to vaccinate children against HPV was declared by 63.3% of respondents. Female gender (OR: 1.42; 95% CI: 1.11–1.81; p < 0.01), age 35–64 years (p < 0.05), having higher education (OR: 1.43; 95% CI: 1.11–1.84; p < 0.01), and living in cities with more than 500,000 residents (OR: 1.51; 95% CI: 1.01–2.28; p < 0.05) were significantly associated with higher odds to hear about the national HPV vaccination program. Age 50 years and over (p < 0.05), having higher education (OR: 1.43; 95% CI: 1.09–1.88; p < 0.05), living in cities with more than 500,000 residents (OR: 1.80; 95% CI: 1.14–2.83; p < 0.05), and no children under 18 in the home (OR: 1.39; 95% CI: 1.01–1.89; p < 0.05) were significantly associated with willingness to vaccinate children against HPV. Full article

(This article belongs to the Special Issue Vaccination Progress in COVID-19 and HPV)

Open AccessArticle

Parental Justifications for Not Vaccinating Children or Adolescents against Human Papillomavirus (HPV)

Eliza S. Rodrigues

Elisa D. T. Mendes

and

Luciana B. Nucci

Vaccines 2023, 11(3), 506; https://doi.org/10.3390/vaccines11030506 - 22 Feb 2023

Viewed by 891

Abstract

Vaccination coverage against Human Papillomavirus (HPV) is low compared with uptake of other vaccines in many countries, including Brazil. The aim of this study was to examine the main reasons provided by parents or guardians of a target population that did not have the first dose of HPV vaccine in a small rural Brazilian municipality, and to verify the factors associated with the reasons for non-vaccination. This is a cross-sectional study with interviews based on the Health Belief Model (HBM), conducted with parents and guardians of 177 unvaccinated children or adolescents. The outcome of interest was the main reason for not vaccinating the child/adolescent. The exposure factors of interest were knowledge about HPV and its prevention as well as sociodemographic characteristics. The main justifications for not vaccinating were lack of information (62.2%), fear or refusal (29.9%), and logistical issues (7.9%). The justifications associated with adolescents’ sex, fear, or refusal were mentioned by 39.3% (95% CI: 28.8–50.6%) of parents or guardians of girls and by 21.5% (95% CI: 13.7–31.2%) of parents or guardians of boys. The main barrier to HPV vaccination is lack of information. Further training of health professionals in clarifying the benefits of vaccination and differentiating the risks between boys and girls could encourage uptake. Full article

(This article belongs to the Special Issue Vaccination Progress in COVID-19 and HPV)

► Show Figures

Figure 1

Other

Jump to: Research

Open AccessSystematic Review

Acceptability of HPV Vaccines: A Qualitative Systematic Review and Meta-Summary

María-Teresa Urrutia

Alejandra-Ximena Araya

and

Vaccines 2023, 11(9), 1486; https://doi.org/10.3390/vaccines11091486 - 14 Sep 2023

Viewed by 362

Abstract

In 2006, the human papillomavirus (HPV) vaccine was approved for use as an effective intervention for reducing the risk of developing cervical cancer; however, its successful implementation is dependent on acceptability. This study aims to provide a comprehensive understanding of the reasons that favor or do not favor the acceptability of HPV vaccines. Methods: We conducted a systematic review and meta-summary of qualitative research on 16 databases. A total of 32 articles that considered the perspectives of vaccine users, their parents, and the professionals who care for them were reviewed. Synthesis was conducted as described by Sandelowski and Barroso. Results: We used inductive and deductive methods to obtain a total of 22 dimensions, out of which three issues stood out that should be considered to improve acceptability and are formed by three groups of study, namely, information about the vaccine, fears and side effects, and sexuality associated with the vaccine. Conclusions: Acceptability, as well as adherence to HPV vaccination, is a complex concept. This review highlights the perspectives of the three sets of actors involved in the process (i.e., users, parents, and professionals) and views these factors in relation to acceptability as a guide for new interventions. Full article

(This article belongs to the Special Issue Vaccination Progress in COVID-19 and HPV)

► Show Figures

Journal Menu

Journal Browser

Special Issue "Vaccination Progress in COVID-19 and HPV"

Share This Special Issue

Special Issue Editor

Special Issue Information

Keywords

Published Papers (3 papers)

Research

Other

Further Information

Guidelines

MDPI Initiatives

Follow MDPI